Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Canopy Growth Corp (CGC) vs Altria Group Inc (MO) Price & Performance

Canopy Growth CorpTrade
Altria Group IncTrade

Price performance (Past 24H)

Key statistics

Canopy Growth Corp vs Altria Group Inc — how do they compare? Canopy Growth Corp trades at $1.02 (market cap $421.10M), while Altria Group Inc trades at $64.81 (market cap $108.58B). The key difference: Altria Group Inc is far larger — about 257.8× Canopy Growth Corp's market cap, and Altria Group Inc pays a 6.52% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.

CGCMO
Market Cap
$421.10M$108.58B
Sector
HealthConsumer Staples
52-Week High
$1.92$74.92
52-Week Low
$0.86$54.72
Enterprise Value
$378.55M$130.79B
Dividend Yield
6.52%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Canopy Growth Corp

CGC trades at $0.95, down 1.86% in the last session, with a neutral technical signal and mixed analyst ratings (9 buy, 11 hold, 7 sell). The company reported Q1 2027 revenue growth of 13% year-over-year, beating estimates, but continues to post net losses. Recent news highlights expansion in European cannabis markets and cost-cutting efforts, while the stock remains volatile amid regulatory uncertainty.

Outlook is cautious due to persistent losses and high debt, though improving cash flow and revenue growth offer potential upside. Key risks include regulatory delays in U.S. cannabis rescheduling and competitive pressures. Investors should weigh the speculative nature against any positive regulatory catalysts.

Altria Group Inc

Altria Group (MO) trades at $65.54, down 4.11% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with a 39% net income margin and attractive 6.3% dividend yield, though cigarette volume declines persist. Recent Q2 2026 earnings missed expectations, triggering price weakness and multiple legal investigations into potential securities violations. Analyst consensus remains positive with 61.5% buy ratings and $67 price target, but technical indicators suggest near-term pressure with support at $62-65.

MO presents a value opportunity for income investors with its high yield and reasonable P/E of 13.7, though regulatory risks and declining traditional tobacco business create headwinds. The smoke-free product expansion offers growth potential, but legal uncertainties and volume erosion require careful monitoring. Current levels near support provide entry points for dividend-focused investors willing to accept sector-specific risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Canopy Growth Corp

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more on CGC

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

Read more on MO